Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Statistics and Data Center, Samsung Medical Center, Seoul, South Korea.
Respir Med. 2019 May;151:1-7. doi: 10.1016/j.rmed.2019.03.014. Epub 2019 Mar 26.
Information about the natural history of nontuberculous mycobacterial pulmonary disease (NTM-PD) is limited. The purpose of this study was to evaluate the long-term natural history of non-cavitary nodular bronchiectatic NTM-PD and the factors associated with treatment initiation and the frequency of spontaneous sputum culture conversion after diagnosis of NTM-PD.
We evaluated 1,021 patients with newly diagnosed non-cavitary nodular bronchiectatic NTM-PD caused by Mycobacterium avium complex or M. abscessus between 2003 and 2013.
Of 1,021 patients, 562 (55%) initiated antibiotic treatment and 459 (45%) did not. Young age (adjusted hazard ratio [aHR] = 0.99; 95% confidence interval [CI] = 0.98-0.99), low body mass index (aHR = 0.96; 95% CI = 0.93-0.99), previous history of tuberculosis (aHR = 1.23; 95% CI = 1.01-1.50), respiratory complaints such as cough (aHR = 1.36; 95% CI = 1.05-1.75) and sputum production (aHR = 1.47; 95% CI = 1.13-1.91), and high number of involved lobes on high-resolution computed tomography (aHR = 1.22; 95% CI = 1.14-1.31) were associated with treatment initiation. Of 459 patients who did not initiate treatment, 157 (34%) showed spontaneous sputum culture conversion. None of the clinical factors was associated with spontaneous conversion. After spontaneous culture conversion, 26 of 157 (17%) showed redeveloped NTM-PD caused by a species different from the original species.
The natural history of non-cavitary nodular bronchiectatic NTM-PD is variable. After diagnosis, the decision to initiate antibiotic therapy should be individualized based on consideration of the risk factors for disease progression. However, for patients who do not start antibiotic therapy, continuous and lifetime follow-up is recommended to manage underlying bronchiectasis and the possibility of late progression of NTM-PD.
非结核分枝杆菌肺病(NTM-PD)的自然史信息有限。本研究旨在评估非空洞性结节性支气管扩张性 NTM-PD 的长期自然史,以及与 NTM-PD 诊断后开始治疗和自发痰培养转化频率相关的因素。
我们评估了 2003 年至 2013 年间由鸟分枝杆菌复合体或脓肿分枝杆菌引起的新诊断的非空洞性结节性支气管扩张性 NTM-PD 的 1021 例患者。
在 1021 例患者中,562 例(55%)开始接受抗生素治疗,459 例(45%)未接受治疗。年龄较小(调整后的危险比[aHR] = 0.99;95%置信区间[CI] = 0.98-0.99)、低体重指数(aHR = 0.96;95%CI = 0.93-0.99)、既往结核病史(aHR = 1.23;95%CI = 1.01-1.50)、咳嗽(aHR = 1.36;95%CI = 1.05-1.75)和咳痰(aHR = 1.47;95%CI = 1.13-1.91)等呼吸道症状,以及高分辨率计算机断层扫描(HRCT)显示受累肺叶数较多(aHR = 1.22;95%CI = 1.14-1.31)与治疗开始相关。在未开始治疗的 459 例患者中,157 例(34%)自发痰培养转为阴性。没有任何临床因素与自发转换相关。自发培养转化后,157 例中有 26 例(17%)出现了与原菌种不同的新 NTM-PD。
非空洞性结节性支气管扩张性 NTM-PD 的自然史是多变的。诊断后,应根据疾病进展的危险因素个体化决定是否开始抗生素治疗。然而,对于未开始抗生素治疗的患者,建议持续终生随访,以管理潜在的支气管扩张症,并管理 NTM-PD 晚期进展的可能性。